Effects of Age on Lipid Nanoparticle Delivery and mRNA Vaccination
年龄对脂质纳米颗粒递送和 mRNA 疫苗接种的影响
基本信息
- 批准号:10605919
- 负责人:
- 金额:$ 4.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAffectAgeAgingAntibody ResponseAntibody titer measurementBiodistributionBiologicalBiological AssayCellsCirculationClinicalCommunicable DiseasesDataDevelopmentDoseEbolaElderlyEnzyme-Linked Immunosorbent AssayEpidemicFlow CytometryForeign BodiesFormulationGoalsHealthcareImmuneImmune responseImmune systemImmunityImmunologicsImmunologyImpairmentIntramuscularIntramuscular InjectionsKineticsMeasuresMediatingMemoryMemory B-LymphocyteMessenger RNAMethodsModelingMusOutcomeOvalbuminPatientsPerformancePersonsPharmaceutical PreparationsPhysiologicalPopulationPositioning AttributePredispositionProcessProteinsRNA deliveryRNA vaccinationRNA vaccineRecording of previous eventsReporterResearchResearch PersonnelSerologyStructureSubgroupSystemT-LymphocyteTestingTherapeuticTimeTissuesToxic effectToxicologyTransfectionVaccinationVaccine ProductionVaccinesVariantVulnerable PopulationsWorkage effectage groupage relatedclinically significantcytokinedesigndosageefficacy evaluationexperiencefightingglobal healthhuman old age (65+)immune activationimmunogenicimmunogenicityimprovedin vivo imaginginfection rateinnovationlipid nanoparticlenanoparticlenanoparticle deliverynanoprocessnext generationpandemic diseaseprophylacticresponsesenescencesexuptakevaccination outcomevaccine developmentvaccine efficacyvaccine immunogenicityvaccine responsevaccinologyyoung adult
项目摘要
PROJECT ABSTRACT
The goal of this research is to study the influence of age on the delivery processes required for lipid
nanoparticle-mediated mRNA vaccination, with a long-term goal of improving vaccination outcomes in the
elderly. In the next thirty years, our elderly population will double, exceeding 1.6 billion people worldwide.
Unfortunately, a declining immune system makes elderly people susceptible to an array of deadly infectious
diseases, placing additional burdens on global healthcare, particularly during epidemics and pandemics such
as Ebola and SARS-CoV-2. There is a real need for effective prophylactics that protect vulnerable populations.
Messenger RNA (mRNA) has emerged as a revolutionary platform that has catalyzed the fastest development
of vaccines in history and bolstered the fight against SARS-CoV-2. However, early data suggest that these
vaccines elicit an age-dependent immune response. The diminished antibody response of these vaccines in
the elderly can substantially curtail their duration of protection. There is an urgent need to understand mRNA
delivery as a function of age and develop potent and safe vaccines that can protect people across all age
groups. While other researchers are examining age-related immune system impairment, this research is
unique because it will determine age-related effects on the lipid nanoparticle (LNP) mRNA delivery
process. This will enable the decoupling of impaired delivery and diminished immune responses on mRNA
vaccination in the elderly. I am well-poised to conduct this research, given my preliminary data and the
expertise of the Whitehead and Weissman labs with LNP delivery, immunology, and vaccinology.
Although measuring post-vaccination infection rates and antibody titers as a function of age is
important, these endpoints do not capture the effect of age on critical intermediate steps during mRNA
vaccination. I hypothesize that differences in delivery contribute to reductions in mRNA-induced immunity. To
test this hypothesis, I will determine to what extent age affects lipid nanoparticle mRNA delivery endpoints (Aim
1) and immune responses (Aim 2), allowing the two to be decoupled. In Aim 1, I will determine the efficacy,
biodistribution, targeted cell population, immunogenicity, and toxicity of five top-performing lipid nanoparticles
following intramuscular injection in young and old mice of both sexes. In Aim 2, I will elucidate the impact of
age on the immune response of mRNA-LNPs. From Aim 2.1, we will select a top-performing LNP to investigate
further in a vaccine kinetics study (Aim 2.2). Aims 1 and 2 combined will reveal LNP structures that confer the
most robust immune response in young and old mice and aid the development of more efficacious mRNA
vaccines for the elderly.
This work is innovative because we will study how age impacts the process of nanoparticle delivery, which has
not been conducted comprehensively for mRNA-LNPs. In the long term, our discoveries will have clinical
significance because they will help tailor the design of LNP delivery systems for the elderly.
项目摘要
本研究的目的是研究年龄对脂质所需的分娩过程的影响。
纳米颗粒介导的mRNA疫苗接种,其长期目标是改善
老人在未来30年,我们的老年人口将翻一番,超过16亿人。
不幸的是,免疫系统的下降使老年人容易受到一系列致命的传染病的影响。
疾病,给全球卫生保健带来额外负担,特别是在流行病和大流行病期间,
埃博拉和SARS-CoV-2。真实的需要有效的预防措施来保护弱势群体。
信使RNA(mRNA)已经成为一个革命性的平台,催化了最快的发展
并支持了抗击SARS-CoV-2的斗争。然而,早期数据表明,这些
疫苗引发年龄依赖性免疫应答。这些疫苗的抗体反应减弱,
长者可大大缩短保障期。迫切需要了解mRNA
根据年龄提供疫苗,并开发有效和安全的疫苗,可以保护所有年龄段的人
组当其他研究人员正在研究与年龄相关的免疫系统损伤时,这项研究是
独特的,因为它将确定脂质纳米颗粒(LNP)mRNA递送的年龄相关效应
过程这将使受损的递送和mRNA上减弱的免疫应答脱钩
老年人接种疫苗。我准备好进行这项研究,鉴于我的初步数据和
Whitehead和Weissman实验室在LNP递送、免疫学和疫苗学方面的专业知识。
虽然测量接种后感染率和抗体滴度作为年龄的函数是可行的,
重要的是,这些终点并没有捕捉到年龄对mRNA表达过程中关键中间步骤的影响。
预防针我推测,不同的交付有助于减少mRNA诱导的免疫力。到
为了验证这一假设,我将确定年龄在多大程度上影响脂质纳米颗粒mRNA递送终点(Aim
1)和免疫反应(目标2),使两者脱钩。在目标1中,我将确定疗效,
五种性能最佳的脂质纳米粒的生物分布、靶向细胞群、免疫原性和毒性
在两种性别的年轻和年老小鼠中肌内注射后。在目标2中,我将阐明
年龄对mRNA-LNP免疫应答的影响。从目标2.1中,我们将选择一个性能最佳的LNP进行研究
进一步在疫苗动力学研究中(目标2.2)。目标1和2结合起来将揭示LNP的结构,
在年轻和年老的小鼠中最强大的免疫反应,并帮助开发更有效的mRNA
老年人的疫苗。
这项工作是创新的,因为我们将研究年龄如何影响纳米颗粒输送的过程,
尚未对mRNA-LNP进行全面研究。从长远来看,我们的发现将具有临床意义。
这是一项重要的工作,因为它们将有助于为老年人量身定制LNP输送系统的设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mariah Arral其他文献
Mariah Arral的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 4.38万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 4.38万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 4.38万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 4.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 4.38万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 4.38万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 4.38万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 4.38万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 4.38万 - 项目类别:
Miscellaneous Programs